Traders could go long on the eye-care company on strength above $62 risking below $59 with a $72 price target.
MN looks like it could move higher and rally, but the uneven trading pattern tells me to look for easier set-ups.
The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.
Let's check out the charts and indicators.
Let's check out the charts and indicators of this medical equipment maker.
Shares of Fitbit were hammered on Thursday after the smartwatch maker lowered expectations for the full year.
Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.
Here's how to trade the stock right now.
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.